Tilmann Bürckstümmer

4.6k citations
24 papers · 3.2k indexed · 1 hit paper · h-index 19
  • Immunology top 2%
    • interferon and immune responses 6
    • Mast cells and histamine 3
    • Immune Response and Inflammation 3
  • Virology top 5%
    • CRISPR and Genetic Engineering 7
    • RNA Interference and Gene Delivery 3
    • Advanced biosensing and bioanalysis techniques 3
    • Inflammasome and immune disorders 3
    • Receptor Mechanisms and Signaling 3
  • Aging top 10%
  • Hepatology top 10%

Tilmann Bürckstümmer

24 papers receiving 3.2k citations

Hit Papers

An orthogonal proteomic-genomic screen identifies AIM2 as...8522009202620142020250500750

Peers

Tilmann Bürckstümmer
Comparison fields: 5 of 104
  • Immunology 1.5k
  • Virology 150
  • Molecular Biology 2.1k
  • Aging 28
  • Hepatology 116
Replace Karsten Sauer with:
Karsten Sauer United States
Nobuo Sakaguchi Japan
Roger R. Beerli Switzerland
Sibylle Mittnacht United Kingdom
Marissa Vignali United States
Donald Dowbenko United States
Cécile Chalouni United States
F. Nina Papavasiliou United States
Peter M. Kloetzel Germany
Robert B. DuBridge United States
Tilmann Bürckstümmer relative to Karsten Sauer United States Karsten Sauer's profile →
Citations per field
00.5×1.5×2.2×
Karsten Sauer · 1×
Citations per year

Countries citing papers authored by Tilmann Bürckstümmer

Since Specialization
Citations

This map shows the geographic impact of Tilmann Bürckstümmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Bürckstümmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Bürckstümmer more than expected).

Fields of papers citing papers by Tilmann Bürckstümmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilmann Bürckstümmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Bürckstümmer. The network helps show where Tilmann Bürckstümmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tilmann Bürckstümmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tilmann Bürckstümmer Line = papers co-authored together Tilmann Bürckstümmer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202118
2 2019148
3 201714
4 201618
5 201612
6 2015146
7 2014204
8 2012111
9 2011111
10 2011372
11 201160
12 200930
13 200931
14
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasomebreakdown →
2009852
15 2008267
16 2006312
17 200569
18 200369
19 200253
20 200166

About Tilmann Bürckstümmer

Tilmann Bürckstümmer is a scholar working on Immunology, Molecular Biology and Hepatology, having authored 24 papers that have together received 3.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), interferon and immune responses (6 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Inflammasome and immune disorders (3 papers), Mast cells and histamine (3 papers), Immune Response and Inflammation (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Immunology (1.5k citations), Virology (150 citations) and Molecular Biology (2.1k citations). Tilmann Bürckstümmer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Giulio Superti‐Furga, Keiryn L. Bennett, Jacques Colinge, Christoph Baumann, Melanie Planyavsky, Oliver Hantschel, Evelyn Dixit, Martin Bilban, Gerhard Dürnberger and Stephan Blüml. Their work appears in journals such as Nature Methods, Nature Immunology, Cytokine, Journal of Pharmacology and Experimental Therapeutics and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026